ArticleBiomolecules & therapeutics2022

Combination Therapy of the Active KRAS-Targeting Antibody inRas37 and a PI3K Inhibitor in Pancreatic Cancer.

Ji Eun Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.